ASX:CSL CSL (CSL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CSL Stock (ASX:CSL) 30 days 90 days 365 days Advanced Chart Get CSL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationA$77.43 billionP/E Ratio28.02Dividend Yield1.56%Price TargetN/AConsensus RatingN/A Company Overview CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Read More Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address CSL Stock News HeadlinesBMW M Plans A Flagship ‘Dream Car’ For CollectorsJuly 3 at 6:22 PM | msn.comHere are the latest growth forecasts for the CSL share priceJuly 3 at 5:11 AM | msn.comWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly becoming one of the most profitable stories of the year. | True Market Insiders (Ad)BMW M4 CSL with Modified Exhaust – Brutal Accelerations & Downshifts!July 3 at 5:11 AM | msn.comChinese football club's bus seized over unpaid debts, players forced to ride bicycle homeJuly 1 at 10:04 AM | msn.comCSL to build two tugs for Polestar Maritime LtdJune 30, 2025 | msn.comNow trading at an 'attractive price', why CSL shares look set for a reboundJune 29, 2025 | msn.comBMW M3 CSL E46 vs VW Bora VR6 – ¼ Mile Drag Race | Acceleration & Sound Battle (Viertelmeile Rennen)June 29, 2025 | msn.comSee More Headlines CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) issued its earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.22 by $0.01. CSL had a net margin of 18.41% and a trailing twelve-month return on equity of 15.37%. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some other companies that CSL investors own include Cochlear (COH), Mineral Resources (MIN), ResMed (RMD), Magellan Financial Group (MFG), NIB (NHF), Accent Group (AX1) and Corporate Travel Management (CTD). Company Calendar Last Earnings8/14/2019Ex-Dividend for 4/8 Dividend3/09/2025Record date for 4/8 Dividend4/08/2025Dividend Payable4/08/2025Today7/03/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryRubber And Plastic Products Current SymbolASX:CSL CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees12,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$7.88 Trailing P/E Ratio28.02 Forward P/E RatioN/A P/E Growth1.29Net IncomeA$2.64 billion Net Margins18.41% Pretax MarginN/A Return on Equity15.37% Return on Assets6.56% Debt Debt-to-Equity Ratio64.46 Current Ratio1.86 Quick Ratio1.68 Sales & Book Value Annual SalesA$14.80 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$42.52 per share Price / BookN/AMiscellaneous Outstanding Shares484,210,000Free FloatN/AMarket CapA$77.43 billion OptionableNot Optionable Beta0.32 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (ASX:CSL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.